Part I: Update on Prostate Tumor Pathology
1: Anatomy of the Prostate Revisited: Implications for Prostate Biopsy and Zonal Origins of Prostate Cancer
Samson W. Fine and Rohit Mehra
2: Contemporary Gleason Grading System
Kiril Trpkov
3: Contemporary Prostate Cancer Staging
Christopher G. Przybycin, Sara M. Falzarano, and Cristina Magi-Galluzzi
4: Prostate Cancer Reporting on Biopsy and Radical Prostatectomy Specimens
Samson W. Fine
5: Unusual Epithelial and Non-Epithelial Neoplasms of the Prostate
Adeboye O. Osunkoya and Cristina Magi-Galluzzi
6: Management Implications Associated with Unusual Morphologic Entities of the Prostate
Viraj A. Master, Jonathan Huang, Cristina Magi-Galluzzi, and Adeboye O. Osunkoya
7: Nomograms for Prostate Cancer Decision-Making
Cesar E. Ercole, Michael W. Kattan, and Andrew J. Stephenson
8: Genetic Determinants of Familial and Hereditary Prostate Cancer
Jesse K. McKenney, Christopher G. Przybycin, and Cristina Magi-Galluzzi
9: New Molecular Markers of Diagnosis and Prognosis in Prostate Cancer
Rajal B. Shah and Ritu Bhalla
10: Intraoperative Consultation for Prostate Tumors: Challenges
and Implications for TreatmentHiroshi Miyamoto and Steven S. Shen
11: Genomics and Epigenomics of Prostate Cancer
Juan Miguel Mosquera, Pei-Chun Lin, and Mark A. Rubin
Part II: Update on Bladder Tumor Pathology
12: Anatomy of the Urinary Bladder Revisited: Implications for Diagnosis and Staging
of Bladder Cancer
Victor E. Reuter
13: Classification and Histologic Grading of Urothelial Neoplasms by the WHO 2004 (ISUP 1998) Criteria
Jesse K. McKenney
14: Reporting of Bladder Cancer in TURBT and Cystectomy Specimens
Jesse K. McKenney
15: Urothelial Carcinoma Variants: Morphology and Association with Outcomes
Gladell P. Paner and Donna E. Hansel
16: Independent Predictors of Clinical Outcomes and Prediction Models on Bladder and Upper Urinary Tract Cancer
Maria Carmen Mir, Andrew J. Stephenson, and Michael W. Kattan
17: Familial Urothelial Carcinomas
Christopher G. Przybycin and Jesse K. McKenney
18: New Molecular Markers with Diagnostic and Prognostic Values in Bladder Cancer
Hikmat A. Al-Ahmadie and Gopa Iyer
19: Intraoperative Consultation for Bladder Tumors: Challenges
and Implications for TreatmentHiroshi Miyamoto and Steven S. Shen
20: Genetic and Epigenetic Alterations in Urothelial Carcinoma
Hikmat A. Al-Ahmadie and Gopa Iyer
21: Urine Cytology
Jordan P. Reynolds
Part III: Update on Renal Tumor Pathology
22: Anatomy of the Kidney Revisited: Implications for Diagnosis and Staging of Renal Cell Carcinoma
Stephen M. Bonsib
23: Classification of Adult Renal Tumors and Grading of Renal Cell Carcinoma
William R. Sukov and John C. Cheville
24: Tumor Staging for Renal Pathology
Stephen M. Bonsib
25: Surgical Pathology Reporting of Renal Cell Carcinomas
Christopher G. Przybycin, Angela Wu, and Lakshmi P. Kunju
26: Newly Described Entities in Renal Tumor Pathol
About the Author:
Cristina Magi-Galluzzi, MD, PhD
The Cleveland Clinic
Department of Pathology
Robert J Tomsich Pathology and Laboratory Medicine Institute
Cleveland, OH, USA
Christopher G. Przybycin, MD
The Cleveland Clinic
Department of Pathology
Robert J Tomsich Pathology and Laboratory Medicine Institute
Cleveland, OH, USA
